Preparation, characterization and pharmacodynamic evaluation of fused dispersions of Simvastatin using PEO-PPO block copolymer

Iranian Journal of Pharmaceutical Research

Volumn 11, Issue 2, 2012, Pages 433-445

  Philip, Betty ^a   Singh, Harjeet ^b   Pathak, Kamla ^b  

^a UNIVERSITY OF NIZWA   (Oman)

^b Rajiv Academy for Pharmacy ^*  (India)

Author keywords

crystallanity index; Inverse thermo sensitivity; Lutrol NF 127 prill surfactant; Optimization

Indexed keywords

COPOLYMER; ETHYLENE; OXYETHYLENE; PHOSPHATE BUFFERED SALINE; POLOXAMER; SIMVASTATIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DISSOLUTION; DRUG ACTIVITY; DRUG ANALYSIS; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; FEMALE; INFRARED SPECTROSCOPY; MALE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SCANNING ELECTRON MICROSCOPY; TEMPERATURE MEASUREMENT; THERMOGRAPHY; X RAY DIFFRACTION;

EID: 84862726882     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Vasconcelos T, Sarmento B and Costa AO. Solid dispersions as strategy to improve oral bioavailability of poor water-soluble drugs. Discovery Today (2007) 12: 1068-1074.
2. Leuner C and Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. (2000) 50: 47-60.
3. Mortazavi SA. Advances in targeted drug delivery. Iranian J. Pharm. Res. (2007) 6: 149-150.
4. Tanaka N, Imai K, Ueda S and Kimura T. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilcadipine (II): in-vivo evaluation. J. Cont. Rel. (2006) 122: 51-56.
5. Ahuja N, Prakash O and Singh B. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. Eur. J. Pharm. Biopharm. (2007) 65: 26-38.
6. Chiou WL and Rigelman S. Pharmaceutical application of solid dispersion system. J. Pharm. Sci. (1971) 60: 1281-1302.
7. Serajuddin A. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems and recent breakthroughs. J. Pharm. Sci. (1999) 88: 1058-1066.
8. Sekiguchi K and Obi N. Studies on absorption of eutectic mixture-I. Chem. Pharm. Bull. (1961) 9: 866-872.
9. Yamamura S and Rogers LA. Characterization and dissolution behavior of nifedipine and phosphatidylcholine binary systems. Int. J. Pharm. (1996) 130: 65-73.
10. Paradkar A, Anshuman A and Mahadik KR. Spray-dried amorphous solid dispersions of simvastatin, a low Tg drug: in-vitro and in-vivo evaluations. Pharm. Res. (2005) 22: 990-998.
11. Patel HR, Patel RP and Patel MM. Poloxamers: A pharmaceutical excipients with therapeutic behaviors. Int. J. Pharmtech. Res. (2009) 1: 299-303.
12. Vippagunta SR, Maul KA and Grant DJW. Solid-state characterization of nifedipine solid dispersions. Int. J. Pharm. (2002) 236: 111-123.
13. Sharma DK and Joshi SB. Solubility enhancement strategy for poorly water-soluble drugs in SD's. Asian J. Pharm. (2007) 1: 9-18.
14. rd ed., Marcel Dekker Inc., New York (1997) 107: 533-569.
15. Wook Jun S, Woo JS and Park HJ. Preparation and characterization of simvastatin/HPβCD inclusion complex using supercritical antisolvent (SAS) process. Eur. J. pharm. Biopharm. (2007) 66: 413-421.
16. Shah TJ, Amin AF, Parikh JR and Parikh RH. Process optimization and characterization of poloxamer solid dispersions of a poorly water-soluble drug. AAPS PharmSciTech. (2007) 29: 1-16.
17. Sethia S and Squillante E. Solid dispersions of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int. J. Pharm. (2004) 272: 1-10.
18. Chen J, Qiu L, Hu M, Jin Y and Han J. Preparation, Characterization and in-vitro evaluation of solid dispersions containing docetaxel. Drug Dev. Ind. Pharm. (2008) 34: 588-594.
19. Goddeeris C and Mooter GDV. Free fowing solid dispersions of anti-HIV drug UC-781 with poloxamer 407 and a maximum amount of TPGS 1000: Investigating the relationship between physiochemical characteristics and dissolution behavior. Eur. J. Pharm. Sci. (2008) 35: 104-113.
20. Ruan LP, Yu YB and Fu GM. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes. J. Pharm. Biomed. Anal. (2005) 38: 457-464.
21. Spulber M, Pintela M and Fifere A. Inclusion complexes of 5-fucytosine with β-CD and HPβ-CD: characterization in aqueous solution and in solid state. J. Incl. Phenom. Macrocycl. Chem. (2008) 1-10.
22. Rajyalakshmi, Reddy ARN and Rajesham VV. A comparative antihyperlipidemic activity of atorvastatin with simvastatin in rats. Int. J. Pharmacol. (2009) 6: 10-13.